EUVIMEDEUVIMED entdecken
Crossref

Capsule endoscopy for small-bowel surveillance in Lynch syndrome patients: a 20-year cohort experience

P. Cortegoso Valdivia, D. Pitoni, G. Mistretta, L. Laghi, M. Pennazio

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S63-S64

DOI: 10.1055/s-0044-1782821 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von P. Cortegoso Valdivia und 4 weiteren Autor:innen. Die Arbeit nennt 2 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Lynch syndrome (LS) is an autosomal dominant hereditary disease caused by germline mutations in the DNA mismatch repair (path_MMR) genes. LS carriers harbor a high risk of developing early-onset gastrointestinal (GI) and extra-GI malignancies, including small-bowel (SB) cancer for which a consensus recommendation for screening is lacking [ 1 ], as recent evidence failed to demonstrate a clear benefit of SB cancer screening with capsule endoscopy (CE) [ 2 ]. Accordingly, our study aims to assess the effectiveness of SB cancer surveillance with CE in a large cohort of LS patients.

Methods

We retrospectively included asymptomatic LS patients undergoing SB cancer surveillance with CE in two academic centers over 20 years (2003-2023). The diagnostic yield (DY) of CE for SB adenomas/adenocarcinomas was assessed, as well as patients’ demographic and path_MMR distribution. Videos were interpreted by expert readers (>1000 lifetime capsules).

Results

57 LS patients (31 females, 26 males) with different path_MMR distribution underwent 81 CE procedures. One patient was excluded from analysis for gastric CE retention. The median age at the first CE examination was 55.5 years (56 patients; interquartile range [IQR] 41–64). In the first screening round, CE detected 4 SB adenocarcinomas (2 in the jejunum and 2 in the ileum) and 4 SB polyps (2 in the ascending duodenum, 10 mm; 2 in the jejunum, 15 mm). The duodenal polyps were subsequently removed by device-assisted enteroscopy (DAE) (histology: tubular adenomas with low-grade dysplasia), whereas both jejunal polyps were considered CE false positives after negative DAE and magnetic resonance enterography (MRE). Therefore, the positive predictive value of CE was 75%, with a DY for histology-confirmed pathology of 10.7%. 16 patients underwent follow-up CE. Of these patients, 3 had a previous positive examination (2 with duodenal polyps and 1 with adenocarcinoma) in the first CE round. In the second-round examination, performed at a median interval of 27 months (IQR 15.5–42.25), all CE were negative (DY 0%). Third- and fourth-round CE examinations have been performed so far in 6 (median interval 22.5 months) and 2 patients (median interval 21 months), respectively: one suspected jejunal polyp (size 10 mm) in the third round was considered CE false positive after negative DAE and MRE (DY 0%). The overall median follow-up time in patients repeating CE (regardless of the number of rounds) was 42 months (IQR 22.25–59.5). No significant differences in the path_MMR distribution were found.

Conclusions

Assuming all normal procedures were true negative (long follow-up, confirmatory tests), CE was effective in diagnosing SB malignancy in a large cohort of asymptomatic LS patients albeit with a considerable amount of false positives, requiring complementary imaging confirmation. Prospective studies are required to establish the potential role of standardized SB cancer surveillance protocols, considering the 0% DY of CE in follow-up procedures. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Valdivia, P. C., Pitoni, D., Mistretta, G., Laghi, L., & Pennazio, M. (2024). Capsule endoscopy for small-bowel surveillance in Lynch syndrome patients: a 20-year cohort experience. Endoscopy, 56(S 02 S 02), S63-S64. https://doi.org/10.1055/s-0044-1782821

Vancouver

Valdivia PC, Pitoni D, Mistretta G, Laghi L, Pennazio M. Capsule endoscopy for small-bowel surveillance in Lynch syndrome patients: a 20-year cohort experience. Endoscopy. 2024;56(S 02 S 02):S63-S64. doi:10.1055/s-0044-1782821

BibTeX
@article{Valdivia2024,
  author = {Valdivia, P. Cortegoso and Pitoni, D. and Mistretta, G. and Laghi, L. and Pennazio, M.},
  title = {Capsule endoscopy for small-bowel surveillance in Lynch syndrome patients: a 20-year cohort experience},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S63--S64},
  doi = {10.1055/s-0044-1782821}
}
Kostenlos starten →